Straits Times Index
3,110.73 +36.47 (+1.19%) Nikkei
32,307.86 -550.45 (-1.68%) Hang Seng
16,334.37 -11.52 (-0.07%) FTSE 100
7,539.19 +25.47 (+0.34%) Bitcoin USD
43,616.72 +368.41 (+0.85%) CMC Crypto 200
900.56 +7.85 (+0.88%)
Kintara Therapeutics, Inc. (KTRA)
Pre-market:
| Previous close | 0.2731 |
| Open | 0.3086 |
| Bid | 0.2478 x 1400 |
| Ask | 0.2400 x 3000 |
| Day's range | 0.2111 - 0.3290 |
| 52-week range | 0.2110 - 15.5000 |
| Volume | |
| Avg. volume | 728,604 |
| Market cap | 880,491 |
| Beta (5Y monthly) | 0.86 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -7.7100 |
| Earnings date | 12 Feb 2024 - 16 Feb 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 14.00 |
PR NewswireKintara Therapeutics Announces Review of Strategic Alternatives
Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that its Board of Directors has initiated a process to explore and review a range of strategic alternatives focused on maximizing stockholder value.
- PR Newswire
Kintara Therapeutics Granted Extension by Nasdaq to Regain Compliance with the Stockholders' Equity Continued Listing Requirement
Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that it received notice from the Staff of the Listing Qualifications Department (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") that the Staff has determined to grant the Company an extension of time to regain compliance with Listing Rule 5550(b) (the "Rule"). The Rule requires a minimum $2,500,000 stockholders
- PR Newswire
Kintara Therapeutics Announces Fiscal 2024 First Quarter Financial Results and Provides Corporate Update
Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced financial results for its fiscal first quarter ended September 30, 2023 and provided a corporate update.
